1. geneticfuture
  2. Growth in commercial disease gene tests, 2008 update

Growth in commercial disease gene tests, 2008 update

By dgmacarthur on March 13, 2009.

I just noticed that GeneTests, a voluntary listing of US and international laboratories offering in-house genetic tests, has released an updated version of their graph of commercially available tests:
i-83718dbd08c637a8e366bca5f05f0510-gene_tests_2008.png

You can see immediately that as the number of tested diseases continues to climb, the number of testing laboratories has plateaued - at least partly the result of more efficient testing methods, and of specialised "boutique" testing labs being swallowed up or out-competed by larger players.

As of today, GeneTests lists 606 laboratories testing for 1,705 diseases; 1,419 of the tests are "clinical" and the remaining 286 are restricted to research applications.

Subscribe to Genetic Future.

Tags
commercial genetic testing
disease genetics

More like this

UK House of Lords report on genomic medicine: implications for DTC genetic testing
The UK House of Lords Science and Technology Committee has published the long-awaited report (PDF) from its inquiry into genomic medicine. Mark Henderson at The Times has been busy today, putting out three excellent pieces on the report: a summary of the major implications, an opinion piece…
Welcome to Genetic Future [Genetic Future]
Welcome to the new look Genetic Future, now hosted on ScienceBlogs. In around five years, a complete genome sequence will be readily affordable for most citizens of wealthy industrialised nations - even those of us on a researcher's salary. At the same time we will have access to vast amounts of…
Welcome to Genetic Future
Welcome to the new look Genetic Future, now hosted on ScienceBlogs. In around five years, a complete genome sequence will be readily affordable for most citizens of wealthy industrialised nations - even those of us on a researcher's salary. At the same time we will have access to vast amounts of…
Observations on the "incidentalome"
Harvard biostatistician Peter Kraft (co-author of an excellent recent article on genetic risk prediction in the New England Journal of Medicine) has just added an interesting comment on his experience of this week's Consumer Genetics Show: I just wanted to share what for me were two stand-out…